Podolec

Journal of Rare Cardiovascular Diseases in EuroPub database Piotr Podolec   Full Text: PDF Abstract n/a DOI: http://dx.doi.org/10.20418%2Fjrcd.vol4no4.418

Holcman

Amyloid cardiomyopathy – the true burden, current approach to diagnosis and treatment (RCD code III‐3A.1, III‐3A.2) Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś Full Text: PDF Abstract n/a Keywords amyloidosis; light-chain amyloidosis; transthyretin amyloidosis; transthyretin; cardiomyopathy; heart failure References Westermark P, Benson MD, Buxbaum JN, et al. Nomenclature Committee of the International Society of […]

Tadesse

Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII) Degena Bahrey Tadesse, Gebreye Yitayih, Weyzer Tilahun, Gebreamlak Gebremedhn, Kiros Belay, Berihu Hailu, Yohannes Ashebir, Gebre Teklemariam Demoz, Mulugeta Molla Full Text: PDF Abstract Objective: Although […]

Tatari

An Extremely Rare Congenital Association: Uni- cuspid Aortic Valve with Left Ventricular Noncom- paction (RCD code: III-5A.1.o) Souzan Tatari Full Text: PDF Abstract Unicuspid aortic valve is a rare congenital abnormality with a prevalence of 0.02% in the adult population. Left ventricular noncompaction is another congenital anomaly with an incidence of 0.05%. Unicuspid aortic valve […]

Kalashnykova

Autoimmune hepatitis induced by bosentan in a patient with pulmonary arterial hypertension (RCD code: II‐1A.1; VIII) Oksana Sergeevna Kalashnykova, Larisa Ivanovna Vasilyeva, Alina Vasilevna Khomich Full Text: PDF Abstract Endothelin receptor antagonist (ERA) therapy‐induced increase in liver transaminases in patients with pulmonary arterial hypertension (PAH) is an adverse effect of bosentan which is not fully […]